Cargando…
The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets
The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19, has led to more than 170 million confirmed cases in 223 countries and regions, claiming 3,872,457 lives. Some patients with COVID-19 have mild clinical symptoms despite severe respiratory...
Autores principales: | Ma, Jianli, Deng, Yuwei, Zhang, Minghui, Yu, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272836/ https://www.ncbi.nlm.nih.gov/pubmed/35801633 http://dx.doi.org/10.1080/21505594.2022.2092941 |
Ejemplares similares
-
Multi-omics for COVID-19: driving development of therapeutics and vaccines
por: Guo, Mengyu, et al.
Publicado: (2023) -
Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With Immunotherapy
por: Ma, Jianli, et al.
Publicado: (2022) -
Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19
por: Singh, Rachana, et al.
Publicado: (2021) -
Prioritization of therapeutic targets for dyslipidemia using integrative multi-omics and multi-trait analysis
por: Kim, Min Seo, et al.
Publicado: (2023) -
Early Prediction of COVID-19 Patient Survival by Targeted Plasma Multi-Omics and Machine Learning
por: Richard, Vincent R., et al.
Publicado: (2022)